灭活鼠新冠单克隆抗体

产品编号MAV109

产品名称Mouse anti-COVID-19/SARS-CoV-2 Monoclonal Antibody (Neutralizing)

抗体亚型IgG1

规格与价格100ul/￥2,300; 500ul/￥6,500

克隆号3F6

产品别名Native SARS-CoV-2 Neutralizing antibody, 2019-nCoV

规格100ul, 500ul

物种COVID-19

宿主Mouse

产品应用ELISA, Neutralization(>1:1024)

内毒素水平<0.1EU/ug determided by LAL method.

缓冲体系0.01M PBS, pH 7.4

免疫原Inactivated Native Virus

产品背景The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; previously provisionally named 2019 novel coronavirus or 2019-nCoV) disease (COVID-19) in China at the end of 2019 has caused a large global outbreak and is a major public health issue. As of 11 February 2020, data from the World Health Organization (WHO) have shown that more than 43 000 confirmed cases have been identified in 28 countries/regions, with >99% of cases being detected in China. On 30 January 2020, the WHO declared COVID-19 as the sixth public health emergency of international concern. SARS-CoV-2 is closely related to two bat-derived severe acute respiratory syndrome-like coronaviruses, bat-SL-CoVZC45 and bat-SL-CoVZXC21. It is spread by human-to-human transmission via droplets or direct contact, and infection has been estimated to have mean incubation period of 6.4 days and a basic reproduction number of 2.24-3.58. Among patients with pneumonia caused by SARS-CoV-2 (novel coronavirus pneumonia or Wuhan pneumonia), fever was the most common symptom, followed by cough. Bilateral lung involvement with ground-glass opacity was the most common finding from computed tomography images of the chest. The one case of SARS-CoV-2 pneumonia in the USA is responding well to remdesivir, which is now undergoing a clinical trial in China. Currently, controlling infection to prevent the spread of SARS-CoV-2 is the primary intervention being used. However, public health authorities should keep monitoring the situation closely, as the more we can learn about this novel virus and its associated outbreak, the better we can respond.

保存条件This product can be stored at 2℃-8℃ for one month. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Avoid repeated freeze-thaw cycles.

备注This product is used for research use only. Not for human or diagnostic use.